These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26506065)

  • 21. Botulinum Toxin Type-A (BoNT-A) Injections of the Corrugator Muscles for Aesthetics and Depression?
    Brennan C
    Plast Surg Nurs; 2016; 36(4):167-169. PubMed ID: 27922559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA.
    Nettar KD; Yu KC; Bapna S; Boscardin J; Maas CS
    Arch Facial Plast Surg; 2011; 13(6):380-6. PubMed ID: 21690460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. We are writing in response to the article "Uncommon foreign body reaction caused by botulinum toxin".
    Celik B; Kaya B; Aslan E; Isilgan SE; Gultan S
    J Craniofac Surg; 2013 Jul; 24(4):1501-2. PubMed ID: 23851848
    [No Abstract]   [Full Text] [Related]  

  • 24. Botulinum toxin type A: history and current cosmetic use in the upper face.
    Carruthers A; Carruthers J
    Semin Cutan Med Surg; 2001 Jun; 20(2):71-84. PubMed ID: 11474747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin.
    Carruthers A; Carruthers J
    Dermatol Surg; 1998 Nov; 24(11):1189-94. PubMed ID: 9834738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating facial rejuvenation procedures in the dental practice.
    Roberts W
    Todays FDA; 2013; 25(2):50-3. PubMed ID: 23691617
    [No Abstract]   [Full Text] [Related]  

  • 27. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.
    Carruthers J; Rivkin A; Donofrio L; Bertucci V; Somogyi C; Lei X; Davis PG; Campo A; Beddingfield FC
    Dermatol Surg; 2015 Jun; 41(6):702-11. PubMed ID: 25993609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Information from your family doctor. Cosmetic botulinum toxin injection.
    Am Fam Physician; 2014 Aug; 90(3):Online. PubMed ID: 25077726
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies.
    Cavallini M; Cirillo P; Fundarò SP; Quartucci S; Sciuto C; Sito G; Tonini D; Trocchi G; Signorini M
    Dermatol Surg; 2014 May; 40(5):525-36. PubMed ID: 24575858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering Depressor Anguli Oris for Lower Face Rejuvenation: A Prospective Ultrasound-based Investigation.
    Zhang M; Yang Y; Dong R; Wang L; Sun Y; Li Y; Wang Z; Xu R; Yang W; Jin L; Huang J; Yu N; Long X
    Aesthet Surg J; 2024 Jul; 44(8):880-888. PubMed ID: 38377399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Botulinum toxin injection techniques in the lower third and middle of the face, the neck and the décolleté: the "Nefertiti lift"].
    Gassia V; Beylot C; Béchaux S; Michaud T
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S111-8. PubMed ID: 19576476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dilution, storage, and electromyographic guidance in the use of botulinum toxins.
    Mantell AM
    Dermatol Clin; 2004 Apr; 22(2):135-6, v. PubMed ID: 15222572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Uses of AbobotulinumtoxinA in Aesthetics.
    Schlessinger J; Gilbert E; Cohen JL; Kaufman J
    Aesthet Surg J; 2017 May; 37(suppl_1):S45-S58. PubMed ID: 28388720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: "Botulinum toxin type A as a migraine preventive treatment" (Silberstein S, Mathew N, Saper J, Jenkins S, for the BOTOX Migraine Clinical Research Group. Headache. 2000;40:445-450).
    Galvez-Jimenez N; Hanson MR
    Headache; 2001 Jun; 41(6):607. PubMed ID: 11437903
    [No Abstract]   [Full Text] [Related]  

  • 36. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2006 Sep; 25(3):115-21. PubMed ID: 17055389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regarding the treatment of dynamic nasal tip ptosis with botulinum toxin A.
    Ghavami A; Janis JE; Guyuron B
    Plast Reconstr Surg; 2006 Jul; 118(1):263-4. PubMed ID: 16816709
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety and efficacy of administering abobotulinumtoxinA through a single injection point when treating lateral periocular rhytides.
    Kiripolsky MG; Goldman MP
    J Cosmet Dermatol; 2011 Sep; 10(3):232-4. PubMed ID: 21896136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of wrinkles with Botox.
    Klein AW
    Curr Probl Dermatol; 2002; 30():188-217. PubMed ID: 12471713
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of wrinkles with botulinum toxin].
    Lanzl I; Merté RL
    Ophthalmologe; 2007 Sep; 104(9):777-82. PubMed ID: 17823803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.